Feeding Conjugated Linoleic Acid without a Combination of Medium-Chain Fatty Acids during Late Gestation and Lactation Improves Pre-Weaning Survival Rates of Gilt and Sow Progeny

Animal board invited review: Factors affecting the early growth and development of gilt progeny compared to sow progeny

Progeny born to primiparous sows farrowing their first litter, often called gilt progeny (GP), are typically characterised by their poorer overall production performance than progeny from multiparous sows (sow progeny; SP). Gilt progeny consistently grow slower, are born and weaned lighter, and have higher postweaning illness and mortality rates than SP. Collectively, their poorer performance culminates in a long time to reach market weight and, ultimately, reduced revenue. Due to the high replacement rates of sows, the primiparous sow and her progeny represent a large proportion of the herd resulting in a significant loss for the pig industry. While the reasons for poorer performance are complex and multifaceted, they may largely be attributed to the immature age at which gilts are often mated and the significant impact of this on their metabolism during gestation and lactation. As a result, this can have negative consequences on the piglet itself. To improve GP performance, it is crucial to understand the biological basis for differences between GP and SP. The purpose of this review is to summarise published literature investigating differences in growth performance and health status between GP and SP. It also examines the primiparous sow during gestation and lactation and how the young sow must support her own growth while supporting the metabolic demands of her pregnancy and the growth and development of her litter. Finally, the underlying physiology of GP is discussed in terms of growth and development in utero, the neonatal period, and the early development of the gastrointestinal tract. The present review concludes that there are a number of interplaying factors relating to the anatomy and physiology of the primiparous sow and of GP themselves. The studies presented herein strongly suggest that poor support of piglet growth in utero and reduced colostrum and milk production and consumption are largely responsible for the underperformance of GP. It is therefore recommended that future management strategies focus on supporting the primiparous sow during gestation and lactation, increasing the preweaning growth of GP to improve their ability to cope with the stressors of weaning, selection of reproductive traits such as uterine capacity to improve birth weights and ultimately GP performance, and finally, increase the longevity of sows to reduce the proportion of GP entering the herd.

Invited review: strategic adoption of antibiotic-free pork production: the importance of a holistic approach

The discovery of the use of antibiotics to enhance growth in the 1950s proved to be one of the most dramatic and influential in the history of animal agriculture. Antibiotics have served animal agriculture, as well as human and animal medicine, well for more than seven decades, but emerging from this tremendous success has been the phenomenon of antimicrobial resistance. Consequently, human medicine and animal agriculture are being called upon, through legislation and/or marketplace demands, to reduce or eliminate antibiotics as growth promotants and even as therapeutics. As explained in this review, adoption of antibiotic-free (ABF) pork production would represent a sea change. By identifying key areas requiring attention, the clear message of this review is that success with ABF production, also referred to as "no antibiotics ever," demands a multifaceted and multidisciplinary approach. Too frequently, the topic has been approached in a piecemeal fashion by considering only one aspect of production, such as the use of certain feed additives or the adjustment in health management. Based on the literature and on practical experience, a more holistic approach is essential. It will require the modification of diet formulations to not only provide essential nutrients and energy, but to also maximize the effectiveness of normal immunological and physiological capabilities that support good health. It must also include the selection of effective non-antibiotic feed additives along with functional ingredients that have been shown to improve the utility and architecture of the gastrointestinal tract, to improve the microbiome, and to support the immune system. This holistic approach will require refining animal management strategies, including selection for more robust genetics, greater focus on care during the particularly sensitive perinatal and post-weaning periods, and practices that minimize social and environmental stressors. A clear strategy is needed to reduce pathogen load in the barn, such as greater emphasis on hygiene and biosecurity, adoption of a strategic vaccine program and the universal adoption of all-in-all-out housing. Of course, overall health management of the herd, as well as the details of animal flows, cannot be ignored. These management areas will support the basic biology of the pig in avoiding or, where necessary, overcoming pathogen challenges without the need for antibiotics, or at least with reduced usage.